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Plants have provided sources to ﬁnd novel compounds. These plants are being used as
therapeutic purposes since the birth of mankind. The traditional healers normally utilize
medicinal plants as crude drugs while scientists using the folk claim as guides to explore
medicinal plants. Moringa oleifera is a famous edible plant having therapeutic and
nutritive values. The present study was designed to cumulate the research data regarding
to what extent, phytochemical, nutritional and glycemic control studies has been explored
using its different extracts. The articles indicated that the powder, aqueous, methanol and
ethanol extracts of Moringa oleifera (leaves, pods, seeds, stem and root bark) have
signiﬁcant therapeutic herbal potential to treat diabetes mellitus. Collectively, the
mechanism behind is intestinal glucose inhibition, insulin release as well as decrease in
insulin resistance probably regeneration of b-cells of pancreas, increase in glutathione and
reduction in malondialdehyde. Conclusively, this article give descriptive information
about antidiabetic effect, claimed marker compounds and proposed antihyperglycemic
mechanism of a single plant. It can be suggested a potential herbal source to treat diabetes
mellitus as being widely accepted by major population as nutrition and therapeutic agent.1. Introduction
1.1. Diabetes mellitus – a syndrome
Diabetes mellitus is a heterogeneous assembly of syndromes,
with persistent high blood glucose level due to disturbance in
various metabolic processes like glycolysis, Krebs cycle, gluco-
neogenesis, hexose monophosphates hunt pathway, glycogenesis
and glycogenolysis, cholesterol synthesis, synthesis and release
of insulin [1]. According to World Health Organization, it is a
chronic metabolic disorder characterized by common features
of chronic hyperglycemia [2]. The chronic hyperglycemia islinked with long-term damage of organs, particularly the eyes,
kidneys, nerves, heart, and blood vessels [3].
1.2. Drug discovery
The natural sources (plants, animals and microorganisms)
provide a big source for deriving active compounds. Predomi-
nantly, the plant kingdom offers a variety of species act as rem-
edies for several diseases inmany parts of the world [4,5]. As stated
by Newman and Cragg [6] that natural product and their structures
played a highly signiﬁcant role in drug discovery and
development process. These are secondary metabolites like
alkaloids, terpenoids and phenolic compounds, synthesized by
plants as defense against herbivores and pathogens.
1.3. Moringa oleifera Lam. (M. oleifera) tree
M. oleifera Lam. (Moringa pterygosperma Gaertn), belongs
to Moringaceae family of perennial angiosperm plants, having
twelve more species [7] and is a single genus family of shrubs
(Figure 1) [8,9].s article under the CC BY-NC-ND license (http://
Figure 1. M. oleifera tree located in Universiti Sains Malaysia, Pulau
Pinang, Malaysia.
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The local names [10–12] includes: Punjabi (Sohanjna),
Sanskrit (Shigru), Hindi (Soanjna), Bengali (Sajna), Tamil
(Murungai), English (Drum stick tree, Horseradish tree), kelor
tree [13], Nile valley-‘Shagara al Rauwaq’ [14].
1.3.2. Botanical description of M. oleifera
The taxonomic description includes: kingdom: Plantae, sub-
kingdom: Tracheobionta, superdivision: Spermatophyta, divi-
sion: Magnoliphyta, class: Magnoliopsida, subclass: Dilleniidae,
order: Brassicales, family: Moringaceae, genus: Moringa and
species: oleifera [15–17].
All Moringa species are native to Asia, from where they have
been introduced into other warm countries, such as Malaysia and
other tropical countries. The tree can tolerate temperatures from 19
to 28 C [18] and has height from 5 to 10 m and can be cultured
throughout the plains [19]. It tolerates a wide range of rainfall
annually from 250 mm to over 3000 mm [20]. It has nutritive and
pharmacological potentials like antimicrobial, anticancer,
antihyperlipidemic, antidiabetic, antiulcer, analgesic, antifertility,
anticonvulsant, hepatoprotective [21] and just about all parts
(leaves, roots, barks, ﬂowers, pods and seeds) of M. oleifera have
been tested for the treatment of diabetes [22]. Having extensive
nutritive and therapeutic potential, there was no study regarding
cumulative and expanded data about antidiabetic potential of this
plant. Therefore, in this study the effort was made to highlight
the antidiabetic importance ofM. oleifera (Figure 2).Figure 2. Appearance of ﬂowers with bloom on M. oleifera Lam. tree.2. Screening of aqueous leaves extract of M. oleifera
2.1. Streptozotocin (STZ), alloxan-induced, Goto-
Kakizaki (GK) and insulin resistant (IR)-rat models
Many diabetic patients rely on herbal medicines for the
management of their ailment particularly in underdeveloped
subcontinent like Asia [5]. It is estimated that about 80% of the
population in African and Asian countries depend on
conventional medicine for pathology [23] and major population
have an ease access to take such medication as well as locally
well accepted [24]. The M. oleifera being potential therapeutic
agents for diabetes had been used in Wistar and GK rats-model
for type 2 diabetes. Major polyphenols were determined by
high performance liquid chromatography, among them includes:
quercetin glucosides, rutin, kaempferol glycosides, chlorogenic
acids. The leaves signiﬁcantly decreased the fasting blood
glucose (FBG) and improved glucose tolerance with 200 mg/kg
body weight dose at 20, 30, 45 and 60 min for GK rats and at 10,
30 and 45 min for Wistar rats, might be due to the presence of
quercetin-3-glucoside [25]. The blood glucose tolerance
efﬁciency in normal and mildly diabetic mice was 25.99%,
31.25%, 43.19% and 45.17%, 53.31%, 59.16% treated with
100, 200 and 300 mg/100 g body weight, respectively [26].
In another study of 21-days, in normal and mild STZ induced
diabetic rats, a maximum fall observed was 31.1% and 32.8%,
respectively on the 200 mg/kg dose, while in severely diabetics,
fasting blood and postprandial glucose were reduced to 69.2%
and 51.2%, respectively [27]. The extract was evaluated in IR and
type 1 diabetic rat models. In which, IR was induced by high
fructose diet and type 1 diabetes was induced by intraperitoneal
injection of STZ. The results showed increased glucose
intolerance in both IR and STZ diabetic rats, severity being
more in IR rats. Administration of extract with 200 mg/kg dose
for 60 days restored all the alterations near to normal [28].
M. oleifera extracts (stem bark, leaves and root bark) were
mainly consumed as supplement as well as medicine to measure
blood glucose in hyperglycemic rats in this study. The result
declared decrease in body weight and 15 mg/dL reduction in
blood glucose in the group treated with M. oleifera stem bark.
The report also indicated the presence of phytochemicals such as
alkaloids, ﬂavonoids, glycosides, tannins and steroids, respon-
sible for its hypoglycemic effects [29].
In this study, the hypoglycemic and antihyperglycemic effect
was compared with that of glibenclamide and blood glucose
concentration was reduced from (339.00 ± 35.12) to
(129.20 ± 21.31) mg/dL at 200 mg/kg dose [30] at the second
hour in fasted normal and alloxan induced diabetic rabbits.
The maximum percentage reduction was seen with 200 mg/kg
dose when compared to control [31]. Moreover, in another
exploration, tolbutamide (200 mg/kg body weight) was used
as positive control drug and the blood glucose was determined
by 0-toluidine spectrophotometric method at 0, 1, 3 and 6 h
after the administration of extract. The maximum reduction
(P < 0.05) in blood sugar levels of normal and alloxan induced
diabetic rats was found to be 33.18% and 44.96% respectively at
administration of 300 mg/kg dose [32].
The aqueous extract also normalized the elevated serum levels
of glucose, triglycerides, cholesterol, malondialdehyde, and
mRNA expression of the gluconeogenic enzyme pyruvate
carboxylase in hepatic tissues of alloxan-induced diabetic rats. In
addition, it restored the normal histological structure of the liver
Figure 3. M. oleifera leaves.
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decline from (460.10 ± 22.20) and (468.20 ± 16.46) mg/dL to
(124.80 ± 2.48) and (118.00 ± 1.00) mg/dL at the doses of 200
and 400 mg/kg respectively in blood glucose level at day 7, 14,
21 and promotes insulin level through regeneration of b-cells [34].
Multiple dose treatment (250, 500, 1000 mg/kg once a day
for 56 days) with aqueous extract also reduced FBG (P < 0.05),
dose dependant reduction in food intake and body weight as well
as total cholesterol and triglycerides as compared to normal
control in normal Wistar rats [35].
2.2. Comparative study
Comparative study of mistletoe and M. oleifera showed that
after one week of treatment, the glucose and insulin level became
close to normal value. There was also an average increase in
body weight observed for both plants in the third week and sixth
week. Pancreatic malondialdehyde levels in Moringa and
mistletoe treated groups were signiﬁcantly less while superoxide
dismutase and glutathione concentrations increased [36]. In
an added study, M. oleifera was compared with Bridelia
ferruginea leaves in alloxan diabetic rats. The blood glucose
and liver enzymes measurement were done by glucometer
and spectrophotometric methods. The highly signiﬁcant
reduction (P < 0.05) was found in blood glucose and alanine
aminotransferase levels in diabetic rats treated with aqueous
extract of 200, 400 and 800 mg/kg bid for one week [37].
From two groups (15 rats in each),ﬁve animals from each group
were weighed and sacriﬁced. In hyperglycemia, the remaining 10
animals, was induced through intraperitoneal injection of alloxan.
After one week, the animals were treated with 0.5 mL of 30%
aqueous extracts of M. oleifera leaf and Myristica fragrans seed,
respectively for another week. The results indicated signiﬁcant
hypoglycemic effect, increase in body weight and glutathione and
reduction in malondialdehyde concentration in treated rats. There
was also inhibition of superoxide dismutase activity [38].
3. Evaluation of ethanol and methanol extracts
3.1. Ethanol extract
The 70% ethanol extract of M. oleifera leaves was given to
normal and STZ induced diabetic Wistar rats. The two different
doses were administered intraperitoneally against insulin as
positive standard and negative control rats. It was concluded that
the said extract possessed dose dependent antihyperglycemic
activity in STZ induced diabetic Wistar rats only and maximum
reduction was found (74.0 ± 6.6) mg/dL at 7-h at 500 mg/kg body
weight dose [39]. Alike, the 80% ethanol extract ofM. oleifera and
Vernonia amygdalina plants (500 mg/kg dose) were studied
separately and also given as combined treatment in normal and
diabetic rats. After 28-days treatment, the animals were eutha-
nized and blood was collected by cardiac puncture for experi-
mental procedures. There was a signiﬁcant reduction (below
100 mg/dL) in FBG, aspartate aminotransferase and alanine
aminotransferase levels, while increase in total protein was
observed in all treated groups [40]. In a different study, the vacuum
dried 95% ethanol extracts of M. oleifera lowered blood glucose
level close to normal level giving once, twice or thrice daily [41].
The reduction in insulin, liver glycogen, protein, superoxide
dismutase and total antioxidant capacity levels observed in the
STZ-induced control diabetic rats, were reversed by treatmentwith 1 g/kg body weight per day intraperitoneally and 15 g/kg
body weight per day (16% in diet) for 45 daysM. oleifera and also
caused a reduction in blood glucose level in normal rats [42].
Insulin resistance plays a central role in the pathogenesis of
type 2 diabetes mellitus, increase the risk of development and
progression of diabetic complications. The 70% ethanol extract
of M. oleifera leaves (500 and 250 mg/kg body weight for two
weeks) and metformine (320 mg/kg) have been shown to lower
insulin resistance and FBG signiﬁcantly at day 7 and 14 in high-
fat diet and STZ induced diabetic rats [43]. Alcoholic extract of
M. oleifera leaf, moringinine, quercetin and chlorogenic acid
were tested in diabetic rats. The results indicated normalized
elevated serum glucose, triacylglycerol, total cholesterol,
protein carbonyl content, malondialdehyde, total antioxidant
capacity and C-peptide after 21 day therapy at 150 mg/kg
dose. Moreover, it restored the normal histological structure of
the pancreas in diabetic rats. The effects observed due to the
presence of quercetin, chlorogenic acid and moringinine in the
extract [44]. Recently, it is reported that 95% ethanol extract of
M. oleifera leaves have signiﬁcant acute antidiabetic effect at
dose 1 g and 0.5 g/kg body weight orally after 7 h in diabetic
rats while 14-day treatment indicated reduction in cholesterol,
triglyceride and body weight along with antihyperglycemic ef-
fect [45]. The 20%, 40% and 80% ethanol extracts also claimed
its potential in alloxan induced diabetic mice [46].
3.2. Methanol extract
The oral administration of methanol extracts of M. oleifera
300 or 600 mg/kg for six weeks signiﬁcantly (P < 0.001) reduced
lipid-proﬁle and enhanced serum level of high-density lipopro-
tein by 2.4–3.2-fold (Figure 3). Glycogen synthase activities and
glycogen contents were higher and enhanced glucose uptake and
glycogen synthesis through stimulation of insulin release was
noted [47]. Osteoporosis may be the result of diabetes mellitus. In
a different study, M. oleifera was investigated using its different
methanol extracts (leaf, fruit and ﬂower) each with 200 mg/kg
dose on bone health markers in diabetic osteoporosis rats. The
treatment resulted in reduction in glucose levels and so for
increase in ostoblastic marker alanine aminotransferase. Among
all the three parts of M. oleifera exposed, it was fruit which
exhibited the maximum amelioration [48].
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The tablet (98.34% dehydrated M. oleifera leafy powder)
formulation was used to study the antihyperglycemic activity
in 100 type 2 diabetic patients (40–58 years) visiting at private
clinic. There was 28.57% reduction in post-prandial blood
glucose as compared to initial value after 90-days of supple-
mentation, two tablets once a day while glycosylated hemoglobin
was reduced to 7.4% [49]. Likewise, it was found that M. oleifera
leaf powder supplement signiﬁcantly lowered serum glucose in
type 2 diabetes mellitus obese patients. The supplement was
prepared by adding 5% of salt, 7% of red chili powder and 7%
of coriander powder to the dried powder and slightly fried in
open pan without any oil to increase acceptance. The powder
was supplied to all subjects in 50 g pouches and was advised
to use this powder with their food regularly for 40 days [50].
In randomized control design study, 18–55 years old in-
dividuals with low density lipoprotein (LDL) greater than
100 mg/dL were given M. oleifera leaves as commercial 350 mg
capsule (2 capsules tid for 30 days). A signiﬁcant reduction of
13.76 mg/dL LDL concentration verses control was observed and
prevents the rise in serum glucose 2 h after 75 g oral glucose [51].
The effect of M. oleifera and Solanum nigrum was checked
in 20 diabetics and 10 healthy individuals [(35–60) years]. The
glucose concentration, glycosylated hemoglobin, total choles-
terol, triglyceride and low density lipoprotein-cholesterol was
reduced to 22.18, 20.48, 12.45, 39.49 and 17.66% from its initial
value, while high density lipoprotein-cholesterol was increased
to 18.99%. The tannins, phenols, alkaloids, ﬂavonoids and ca-
rotenoids were supposed to be responsible for hypoglycemic
effects [52].
5. M. oleifera pods
The methanol extracts of M. oleifera pods were investigated
in diabetic rats to determine changes in biochemical parameters
in the serum and pancreatic tissue (Figure 4). Two phytocon-
stituents, namely quercetin and kaempferol, were also isolatedFigure 4. M. oleifera pods.from the extract. A signiﬁcant reduction (33.34%) in serum
glucose, increases in serum insulin and protein levels were
observed when diabetic rats were treated with 50 mg/kg body
weight in diet for four weeks. Furthermore, enhanced antioxi-
dant effect also observed in pancreatic tissue and degenerative
changes in the b-cells [53].
6. M. oleifera seeds
The Moringa seed powder was used in diet (100 mg/kg body
weight for four weeks) in STZ induced diabetes male rats.
The diabetic rats ameliorated the levels of all these parameters
(lipid proﬁle, FBG, glycosylate hemoglobin) approaching the
negative control values and restored the normal histology of
both kidney and pancreas [54]. In one more study, the
hypoglycemic effect of M. oleifera seed oil (petroleum ether
and dichloromethane) extracts was carried out in normal rats.
The three different doses of both extracts were tested along
with standard (500 mg/kg body weight) in dimethyl
sulphoxide. The petroleum ether extract showed maximum
reduction (14.10%) in blood glucose level at 2.0 mL/kg dose
while dichloromethane 15.22%. Additionally, acute toxicity
results indicated no sign of toxicity at higher dose up to 5 mL/
kg body weight [55]. Correspondingly, mild and severe
diabetic rats were administered aqueous extract of M. oleifera
seeds with 400 mg/kg body weight orally as well as
intraperitoneally for two weeks. The study indicated a
signiﬁcant decrease in the blood glucose level in acute and
after 14-days chronic study of both oral and intraperitoneal
treatment in mild and severe diabetic rats [56].
7. In-vitro study
7.1. Study on intestinal a-glucosidase enzymes
The a-glucosidase enzymes are located at the intestinal brush
border of the intestine [57,58] which is responsible for the
digestion of carbohydrates and absorption of glucose in the
digestive tract. The management of diabetes can be achieved
by reducing post-prandial hyperglycemia by delaying the activ-
ities of a-amylase and a-glucosidase, respectively [59,60]. The a-
glucosidase, pancreatic a-amylase inhibitory activity, in vitro bile
acid binding capacity, inhibition of cholesterol micellization,
pancreatic lipase, and cholesterol esterase activity were
determined by M. oleifera leaf extract. The extract inhibited a-
glucosidase activity and somewhat pancreatic a-amylase and
cholesterol esterase activity [61]. Among the ethanol extracts of
leaves, roots, ﬂowers, stem and seed, only leaves and seeds
produced signiﬁcant a-amylase and glucosidase inhibitory
activity [62].
7.2. Study on pancreatic b-cells
Pulverized M. oleifera leaves were extracted with dichloro-
methane, acetone, ethyl acetate and water and tested in clonal
pancreatic b-cells. Insulin concentration was measured by
radioimmunoassay and lactate dehydrogenase release by non-
radioactive assay kit (Promega, UK). Amongst, the aqueous
extract produced the best insulinotropic effect, with a maximum
stimulation of 347% (P < 0.001) of basal rate while dichloro-
methane and acetone extracts produced stimulatory effects
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morphometric measurements of b-cells of pancreas (modiﬁed
Gomori's stain) and collagen ﬁbers (Mallory's trichrome stain)
were determined. The plant treatment signiﬁcantly reduced
glucose from 380% to 145%, glutathione from 22% to 73%
and malondialdehyde from 385% to 186% as compared to
control. Morphometric analysis indicated signiﬁcant increased
in the area from 60% to 91% and decreased collagen ﬁbers
from 199% to 120% compared to control values [30].
8. Chemical and phytochemical screening
8.1. Chemical screening
The fresh M. oleifera leaves contained less nutrients as
compared to dried ones, as the dried leaves enclosed 17 times Ca
of the milk, ten times vitamin A of the carrots, 15 times K of the
bananas and 25 times the iron of spinach, 27.2% (protein) or
0.58–0.73 g protein/g, 5.9% moisture, 17.1% fat, 38.6% car-
bohydrates, essential amino acids and carotenoids [64–67]. The
secondary metabolites were also observed, appeared to be
involved in plant defense mechanisms and the trypsin inhibitor
against serine proteinases [68–70].
8.2. Phytochemical screening
Flavonoids and phenolic acids are collectively referred as
phenolic compounds. They are classiﬁed into several subgroups
including: ﬂavone, ﬂavanone, ﬂavonol, isoﬂavonoid, anthocya-
nidin, and chalcones [71].
The high performance liquid chromatography analysis also
indicated the presence of phenolic acids (Gallic, ellagic,
chlorogenic and ferulic acid) and ﬂavonoids: kaempferol, quer-
cetin, isoquercetin, astragalin and rutin [72–76]. Quercetin and
kaempferol, in their as 3-O-glycoside forms were the predomi-
nant ﬂavonols in M. oleifera leaves. The leaves as well enclosed
niazirin, niazirinin, 4-[(40-O-acetyl-Lrhamnosyloxy) benzyl]
isothiocyanate, niaziminin A and B, quercetin-3-O-(600-malonyl-
glucoside), kaempferol-3-O-glucoside and kaempferol-3-O-(600-
malonyl-glucoside), 3-caffeoylquinic and 5-caffeoylquinic acid
[77,78]. It was also reported that the leaves had enough amount of
carotenoids, epicatechin and o-coumaric acid [79].9. Conclusion
It is concluded from the article that the powder, aqueous,
ethanol and methanol extracts of M. oleifera (leaves, seeds,
pods, root and stem bark) provides good glycemic control in
diabetic animal and human models. Preliminary ﬁndings indi-
cated the presence of quercetin glucoside, querecetin and
kaemferol. Cumulatively, the mechanism behind is intestinal
glucose inhibition, insulin release as well decreasing insulin
resistance probably regeneration of b-cells of pancreas, increase
in glutathione and reduction in malondialdehyde. Therefore, it
can be a potential source to treat diabetes and widely accepted
by major population as nutrition and therapeutic agent.Conﬂict of interest statement
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